- Latest available (Revised)
- Original (As adopted by EU)
Commission Implementing Regulation (EU) 2020/484 of 2 April 2020 authorising the placing on the market of lacto-N-tetraose as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version
The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:
in Table 1 (Authorised novel foods), the following entry is inserted in alphabetical order:
Authorised novel food | Conditions under which the novel food may be used | Additional specific labelling requirements | Other requirements | Data Protection | |
---|---|---|---|---|---|
‘Lacto-N-tetraose (“LNT”) (microbial source) | Specified food category | Maximum levels | The designation of the novel food on the labelling of the foodstuffs containing it shall be “lacto-N-tetraose”. The labelling of food supplements containing lacto-N-tetraose shall bear a statement that they should not be used if breast milk or other foods containing added lacto-N-tetraose are consumed the same day. | Authorised on 23.4.2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food lacto-N-tetraose is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. End date of the data protection: 23.4.2025.’ | |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 1,0 g/l | ||||
Unflavoured fermented milk-based products | 1,0 g/l (beverages) 10 g/kg (products other than beverages) | ||||
Flavoured fermented milk-based products including heat-treated products | 1,0 g/l (beverages) 10 g/kg (products other than beverages) | ||||
Beverages (flavoured drinks) | 1,0 g/l | ||||
Cereal bars | 10 g/kg | ||||
Infant formula as defined under Regulation (EU) No 609/2013 | 0,8 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Follow-on formula as defined under Regulation (EU) No 609/2013 | 0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
Processed cereal-based food, baby food for infants and young children as defined under Regulation (EU) No 609/2013 | 0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 5 g/kg for products other than beverages | ||||
Milk based drinks and similar products intended for young children | 0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 5 g/kg for products other than beverages | ||||
Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 | 2,0 g/l (beverages) 20 g/kg (products other than beverages) | ||||
Food for special medical purposes as defined under Regulation (EU) No 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended | ||||
Food Supplements as defined in Directive 2002/46/EC, excluding infants | 2,0 g/day for young children, children, adolescents, and adults |
in Table 2 (Specifications), the following entry is inserted in alphabetical order:
CFU: Colony Forming Units; EU: Endotoxin Units.’ | |
Authorised Novel Food | Specification |
---|---|
‘Lacto-N-tetraose (“LNT”) (microbial source) | Definition: Chemical formula: C26H45O21 Chemical name: β-D-Galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranose Molecular mass: 707,63 Da CAS No 14116-68-8 Description: Lacto-N-tetraose is a purified, white to off-white amorphous powder that is produced by a microbial process. Source: Genetically modified strain of Escherichia coli strain K-12 DH1 Characteristics/Composition: Appearance: White to off-white powder Sum of lacto-N-tetraose, D-Lactose and lacto-N-tetraose II (% of dry matter): ≥ 90,0 % (w/w) Lacto-N-tetraose (% of dry matter): ≥ 70,0 % (w/w) D-Lactose: ≤ 12,0 % (w/w) Lacto-N-tetraose II: ≤ 10,0 % (w/w) Para-lacto-N-hexaose-2: ≤ 3,5 % (w/w) Lacto-N-tetraose fructose isomer: ≤ 1,0 % (w/w) Sum of other carbohydrates: ≤ 5,0 % (w/w) Moisture: ≤ 6,0 % (w/w) Ash, sulfated: ≤ 0,5 % (w/w) pH (20 °C, 5 % solution): 4,0–6,0 Residual protein: ≤ 0,01 % (w/w) Microbiological criteria: Aerobic mesophilic bacteria total plate count: ≤ 1 000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Negative/25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: